ARTICLE | Clinical News
S*BIO, Verastem preclinical data
November 19, 2012 8:00 AM UTC
In a mouse model of breast cancer, 25 mg/kg oral VS-5584 significantly reduced the percent of cancer stem cells in extracted tumors vs. untreated controls. In a mouse model of docetaxel-resistant trip...